—474—第35卷第8期2023年8月Vol.35No.8Aug.2023肝胆胰外科杂志JournalofHepatopancreatobiliarySurgery2013,22(1):59-67.[11]ChenT,JansenL,GondosA,etal.SurvivalofendometrialcancerpatientsinGermanyintheearly21stcentury:Aperiodanalysisbyage,histology,andstage[J].BMCcancer,2012,12:128.[12]LiY,FengA,ZhengS,etal.Recentestimatesandpredictionsof5-yearsurvivalinpatientswithgastriccancer:Amodel-basedperiodanalysis[J].CancerControl,2022,29:10732748221099227.[13]WangY,ZhangL,HanF,etal.UsingPeriodanalysistotimelyassessandpredict5-yearrelativesurvivalforlivercancerpatientsfromtaizhou,easternChina[J].FrontOncol,2022,12:920094.[14]JiangX,WangL,ChengY,etal.Assessmentoflong-termsurvivalofcancerpatientsusingcancerregistrydatafromeasternChina:Periodanalysisissuperiortotraditionalmethods[J].IntJCancer,2020,147(4):996-1005.[15]HolleczekB,GondosA,BrennerH.periodR-anRpackagetocalculatelong-termcancersurvivalestimatesusingperiodanalysis[J].MethodsInfMed,2009,48(2):123-128.[16]洪德飞.《胆囊癌诊断和治疗指南》(2019版)解读[J].肝胆胰外科杂志,2020,32(11):664-666.[17]曾红梅,陈万青.中国癌症流行病学与防治研究现状[J].化学进展,2013,25(9):1415-1420.[18]杨自逸,刘诗蕾,蔡晨,等.胆囊癌临床诊疗的新进展[J].中华外科杂志,2022,60(8):784-791.[19]RahmanR,SimoesEJ,SchmaltzC,etal.TrendanalysisandsurvivalofprimarygallbladdercancerintheUnitedStates:A1973-2009population-basedstudy[J].CancerMed,2017,6(4):874-880.[20]吕文才,邹运,温爽,等.中国胆囊癌发病率及流行趋势分析[J].中华消化外科杂志,2019,18(2):186-189.[21]SharmaA,SharmaKL,GuptaA,etal.Gallbladdercancerepidemiology,pathogenesisandmoleculargenetics:Recentupdate[J].WorldJGastroenterol,2017,23(22):3978-3998.[22]ZhouY,XiangZS,MAJY,etal.SurvivalofcancerpatientsinFujian,SoutheastChina:Apopulation-basedcancerregistrystudy[J].Neoplasma,2021,68(4):892-898.[23]张欢,刘金辉,陈玉,等.农村居民癌症筛查服务需求及支付意愿分析[J].中国公共卫生,2022,38(6):795-759.[24]石景森,任予.中国原发性胆囊癌的流行病学特点[J].中华肝胆外科杂志,2003,9(10):583-584.[25]宋晓玲,梁海滨,王卫民,等.胆囊癌外科治疗与...
